AKR1B1 Protein, Human (His)

Customer Review

Based on 1 Customer Validation

The AKR1B1 protein uses NADPH to reduce various carbonyl compounds to alcohols. AKR1B1 Protein, Human (His) is the recombinant human-derived AKR1B1 protein, expressed by E. coli , with N-10*His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The AKR1B1 protein uses NADPH to reduce various carbonyl compounds to alcohols. AKR1B1 Protein, Human (His) is the recombinant human-derived AKR1B1 protein, expressed by E. coli , with N-10*His labeled tag.

Background

AKR1B1, a versatile enzyme, catalyzes the NADPH-dependent reduction of a diverse array of carbonyl-containing compounds to their respective alcohols. It exhibits enzymatic activity towards endogenous metabolites, including aromatic and aliphatic aldehydes, ketones, monosaccharides, bile acids, and xenobiotics substrates. As a key enzyme in the polyol pathway, AKR1B1 plays a critical role in hyperglycemia by catalyzing the reduction of glucose to sorbitol. The enzyme also reduces steroids and their derivatives, prostaglandins, and displays low activity toward retinals. Additionally, AKR1B1 is involved in the detoxification of dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal, and their glutathione-conjugate carbonyls (GS-carbonyls). Notably, it catalyzes the reduction of various phospholipid aldehydes generated from the oxidation of phosphatidylcholine and phosphatidylethanolamides, further emphasizing its broad substrate specificity and its integral role in cellular detoxification processes.

Verified Bioactivity

Measured by its ability to catalyzes glucuronic acid decomposition in the presence of NADPH. The specific activity is 132.9 U/mg.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

Assay Procedure

Materials
AKR1B1 Protein, Human (His) (HY-P75521): Dissolve in deionized water to a concentration of 100 μg/mL.
Substrate: Glucuronic acid. Accurately weigh 15.520 mg of powder and dissolve in 1 mL of deionized water to a concentration of 80 mM.
Standard: NADPH. Accurately weigh 3.33 mg of solid powder and dissolve in 1 mL of deionized water to a concentration of 4 mM.

Procedure
1. Dilute NADPH to the following concentrations: 0, 0.015625, 0.03125, 0.0625, 0.125, 0.25 mM. Add 200 μL of each concentration to a 96-well plate in triplicate.
2. Measure the absorbance at 340 nm using a microplate reader. Plot a standard curve with the amount of NADPH as the x-axis and the OD value as the y-axis.
3. Dilute the substrate to a concentration of 8 mM for later use.
4. Dilute Human AKR1B1 to 0.2 μg/mL. Mix 50 μL of the substrate with 50 μL of the protein at each concentration, and pre-add to a 96-well plate in triplicate.
5. Dilute 4 mM NADPH to 0.4 mM. Initiate the reaction by adding 100 μL of 0.4 mM NADPH to each well.
6. Zero the microplate reader using the blank group OD value. Measure the absorbance at 340 nm in kinetic mode for 10 min.
7. Define one enzyme unit as the consumption of 1 μmol of NADPH per minute, denoted as U. Calculate the specific enzyme activity.

     Specific Activity (U/mg) =

ΔnNADPH (μmol)
Reaction time (min) x amount of enzyme (mg)

Per Well:
Human AKR1B1: 0.01 μg
Substrate: 2 mM
NADPH: 0.2 mM

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag N-10*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • 10*His
    • AKR1B1 (M1-F316)
      Accession # P15121
    • C-term
  • Protein Length

    Full Length

  • Synonyms

    AKR1B1; ALR2; Prev. ALDR1; Lii5-2 CTCL Tumor Antigen; Aldose Reductase; Low Km Aldose Reductase; AR; Aldehyde Reductase 1; Aldo-Keto Reductase Family 1 Member B1; ADR; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member B; Aldo-Keto Reductase Family 1

  • AA Sequence

    MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF

  • Molecular Weight

    Approximately 36 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder.

Formulation

Lyophilized from a 0.2 μm filtered solution of PB, 150 mM NaCl, pH 7.4.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00